Tags |
|
|
Links |
|
|
Advice You - Five Actions to Avoid in Business Planning
As important as a business plan is, there are also actions that one ought to avoid. We will look at the five most important of them.
The first one seems ob
The first one seems ob
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
vious, no business plan at all. Entrepreneurs are often tempted to believe they don't need a business plan. This overconfidence usually comes from being so
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
confident in our product, vision and ability that we believe we have to succeed. Therefore, why plan, success will happen because of the force of 'rightnes
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
s' and 'destiny.' This is a false sense and can be very destructive. We must avoid this trap and create a plan. It will be to our advantage.
Second is try
Second is try
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
ing to guess what your customers want and need. While it is possible to create needs where none exist, we must be careful to listen to what the customers ar
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
e telling us. They tell us if we have the right product, delivery method and price. A grave mistake would be to ignore signs that some of our business plan
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
assumptions are wrong. The market place and its customers are always right because their perception ultimately leads to our success or failure. If we have
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
made wrong or bad assumptions in our business plan or its implementation, we must correct the plan and our operations.
Too, we must make sure we use our st
Too, we must make sure we use our st
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
rengths. These lead to our market successes. Our business plan must analyze these strengths and outline how we will be using them to supply a need at a pro
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
fit to us. If we are successful in using our strengths and in providing a needed product, we will assure success.
Next, we can't afford to ignore risks. I
Next, we can't afford to ignore risks. I
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
t would be nice not to have them, but the reality is that everything has some risk associated with it. We must recognize the ones that are inherent in our v
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
enture and carefully create methods and plans to mitigate them. Often a business success is dependent on how well we recognized risks in our business plan a
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
nalysis and how appropriately we utilize methods of reducing or eliminating their impacts to us. It is unfortunate that some businesses fail because of unan
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
ticipated risks and, ones they were unable to respond to. At times these risks are apparent to others, but totally missed by business management. Certainly
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
if we don't recognize a risk, our business plan won't address it. Be vigilant for risk indicators we haven't anticipated. Here, an outsider would prove us
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
eful and unbiased in helping us find them.
Finally, we come to a constant in business. Very few things seem constant in a business, but change is one of th
Finally, we come to a constant in business. Very few things seem constant in a business, but change is one of th
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
em. Our world, our views, our social perceptions and our environment cause each of us to change. Business owners must not only accept that change is inevit
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
able, but welcome and plan for it. Change represents a large opportunity to make a difference and a profit. As business owners, we are well advised to addr
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
ess change whenever is arises and use it to improve our business environment. We have the opportunity to make or pass our competition while supplying someth
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
ing that is needed. Thus, change is really the opportunity to improve our business plans and even more an opportunity to increase our success in the venture
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.adviceyou.org.ua/article/44268/adviceyou-Five-Actions-to-Avoid-in-Business-Planning.html">Five Actions to Avoid in Business Planning</a>
BB link (for phorums):
[url=http://www.adviceyou.org.ua/article/44268/adviceyou-Five-Actions-to-Avoid-in-Business-Planning.html]Five Actions to Avoid in Business Planning[/url]
Related Articles:
Career Success - How to Deal With Office Rumours and Gossip
Business to Business Customer Satisfaction Surveys
Bookmark it:
|